New Zealand markets closed

Avid Bioservices, Inc. (CDMO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.70-0.28 (-4.01%)
At close: 04:00PM EDT
6.40 -0.30 (-4.48%)
After hours: 05:43PM EDT

Avid Bioservices, Inc.

14191 Myford Road
Tustin, CA 92780
United States
714-508-6100
https://www.avidbio.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees365

Key executives

NameTitlePayExercisedYear born
Mr. Nicholas Stewart Green B.Sc., MBAPresident, CEO & Director1.35MN/A1965
Mr. Daniel R. HartChief Financial Officer719.75k33.35k1973
Mr. Richard RichieriChief Operations Officer561.68kN/A1965
Mr. Mark R. Ziebell J.D.VP, General Counsel & Corporate Secretary647.1k64.6k1964
Mr. Matthew KwietniakChief Commercial Officer553.59kN/A1969
Ms. Oksana LukashVice President of PeopleN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Corporate governance

Avid Bioservices, Inc.’s ISS governance QualityScore as of 1 March 2024 is 3. The pillar scores are Audit: 9; Board: 2; Shareholder rights: 4; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.